Fibromuscular dysplasia surgery: Difference between revisions
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Revascularization by surgical intervention or percutaneous transluminal angioplasty (PTA) , are not the first-line treatment options for patients with FMD, however in cases of FMD-related RAS with signs of downstream reduction of renal function or in case of drug-resistant HTN vascular reconstruction should be considered. | [[Revascularization]] by surgical intervention or percutaneous transluminal angioplasty (PTA) , are not the first-line treatment options for patients with FMD, however in cases of FMD-related [[RAS]] with signs of downstream reduction of [[renal function]] or in case of drug-resistant HTN vascular reconstruction should be considered. | ||
==Indications== | ==Indications== |
Revision as of 05:26, 25 June 2018
Fibromuscular dysplasia Microchapters |
Diagnosis |
---|
Treatment |
ASA/ACCF/AHA Guideline Recommendations |
Management of Patients With Fibromuscular Dysplasia of the Extracranial Carotid Arteries |
Case Studies |
Fibromuscular dysplasia surgery On the Web |
American Roentgen Ray Society Images of Fibromuscular dysplasia surgery |
Risk calculators and risk factors for Fibromuscular dysplasia surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Revascularization by surgical intervention or percutaneous transluminal angioplasty (PTA) , are not the first-line treatment options for patients with FMD, however in cases of FMD-related RAS with signs of downstream reduction of renal function or in case of drug-resistant HTN vascular reconstruction should be considered.
Indications
- there are no evidence-based guidelines and randomized, controlled trials comparing revascularization and medical therapy in patints with FMD; but ssurgery is usually reserved for patients with either:.
- HTN of recent onset with goal of cure
- drug resistance or intolerance
- renal artey dissection
- Renal artery aneurysm
- preservation of renal function or prevent renal size reduction